top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Nephritic Syndrome



Pathophysiology

  • Glomerular inflammation (glomerulonephritis) leading to haematuria, proteinuria, and renal impairment

  • Immune-mediated injury to glomerular capillaries, resulting in increased permeability and reduced glomerular filtration


Causes


Common causes:

  • Post-infectious GN (e.g., post-streptococcal glomerulonephritis, PSGN)

  • IgA nephropathy (Berger’s disease) – most common, especially in young males of Asian descent, typically 1–2 days post-URTI

  • Small vessel vasculitis (ANCA-associated):

    • Granulomatosis with polyangiitis (Wegener’s)

    • Microscopic polyangiitis

  • Anti-GBM disease (Goodpasture’s syndrome) – associated with pulmonary haemorrhage


Other causes:

  • SLE nephritis (can cause both nephritic and nephrotic syndrome)

  • Membranoproliferative GN (MPGN) – rare, often secondary to autoimmune or chronic infections


Presentation

  • Haematuria – macroscopic (tea/coca-cola coloured urine) or microscopic

  • Hypertension – due to fluid retention and renal impairment

  • Oedema – often periorbital and lower limb

  • Acute kidney injury (AKI) – rising creatinine, reduced eGFR

  • Proteinuria – typically <3.5 g/day (often <1.5 g/day), ACR/PCR <300 mg/mmol


Diagnosis


Initial investigations:

  • Bloods:

    • UEC (assess renal function)

    • FBC (anaemia of chronic disease, infection markers)

    • Complement levels (low in PSGN, lupus nephritis)

    • ASOT (post-streptococcal GN)

    • ANA (SLE), ANCA (vasculitis), anti-GBM (Goodpasture’s)

  • Urine tests:

    • Urinalysis – haematuria, proteinuria

    • Urine microscopy: Red cell casts (specific for glomerular pathology)

    • Urine PCR/ACR (quantify proteinuria) or 24-hour urine protein

    • Urine MCS to exclude infection

  • Imaging:

    • Renal ultrasound – assess kidney size, rule out obstruction

    • Renal biopsy – required for definitive diagnosis


Urine ACR reference range:

  • Normal: Male <2.5 mg/mmol, Female <3.5 mg/mmol

  • Microalbuminuria: Male 2.5–25 mg/mmol, Female 2.5–35 mg/mmol

  • Macroalbuminuria: Male >25 mg/mmol, Female >35 mg/mmol

  • Nephrotic range: >300 mg/mmol


Treatment


General measures:

  • BP control: Aim for <130/80 mmHg

    • ACE inhibitors/ARBs if proteinuria present (reduce glomerular pressure and proteinuria)

  • Salt and fluid restriction if oedema present

  • Diuretics (loop diuretics for volume overload)

  • Immunosuppression:

    • Corticosteroids (especially for IgA nephropathy, SLE nephritis, or vasculitis)

    • Cyclophosphamide/MMF (vasculitis or severe autoimmune causes)


Specific management:

  • PSGN: Supportive care (self-limiting in most cases), antibiotics for active infection

  • IgA nephropathy: BP control, fish oil, consider steroids if progressive disease

  • ANCA-associated vasculitis: High-dose steroids and cyclophosphamide or rituximab

  • Goodpasture’s syndrome: Plasmapheresis, steroids, and cyclophosphamide


Notes

  • IgA nephropathy is the most common cause of primary glomerulonephritis, often seen post-URTI or GI infection

  • Think haematuria workup when considering differentials

  • If urine protein is ≥4 g/day with only mild haematuria, consider nephrotic syndrome instead

  • Early renal biopsy is key in guiding treatment for progressive or uncertain cases​

Bookmark Failed!

Bookmark Saved!

bottom of page